There is so much talk about immunotherapy these days. Sidney Kimmel and Michael Bloomberg just donated money to establish the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University. The Institute of Medicine discussed what policies should be considered with this new emerging treatment paradigm. New ideas about how to combine immunotherapy with other cancer therapies are emerging almost daily. After many years of intense research into how the immune... Read More
Immunotherapy (IT) has changed — and will continue to change — cancer treatment. Although only about 25% of patients who receive IT have a response, when patients do respond to treatment, the response is nothing short of amazing. Patients who just 5 years ago had a 10% chance of survival of over 5 years are now 10 years cancer free with no indication of recurrence. I personally know two people... Read More
It seems you can’t read the health section without finding a story about immunotherapy for cancer treatment. After 30+ years of research, immunotherapy is the latest successful cancer treatment. The success is remarkable. Immunotherapy is changing lives and providing options for a group of people who didn’t have options before. Immunotherapy treatment for cancer was the topic of the Institute of Medicine policy forum held this last week in Downtown... Read More
The bacterial content in your gut (or also called the gut microbiome) may influence how you respond to therapy. This is the conclusion of two separate research papers published in the November 27 issue of Science Magazine. What did these papers actually show? Before getting to the data, it must be noted that this work was all done in a mouse model of cancer. The first lab tested if responses... Read More